Resiniferatoxin in the treatment of interstitial cystitis: A systematic review

International Urogynecology Journal

Volumn 19, Issue 11, 2008, Pages 1571-1576

  Mourtzoukou, Eleni G ^a   Iavazzo, Christos ^a   Falagas, Matthew E ^a,b  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Interstitial cystitis; Painful bladder syndrome; Resiniferatoxin

Indexed keywords

LIDOCAINE; PLACEBO; RESINIFERATOXIN;

ABDOMINAL PAIN; CLINICAL TRIAL; CYSTALGIA; DIZZINESS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; INTERSTITIAL CYSTITIS; MEDICAL LITERATURE; MEDLINE; PALLOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE DATABASE; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SYMPTOM; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 53249085887     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-008-0663-2     Document Type: Review

References (30)

1. Appendino G, Szallasi A (1997) Euphorbium: Modern research on its active principle, resiniferatoxin, revives an ancient medicine. Life Sci 60:681-696
2. Szallasi A, Blumberg PM (1989) Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 30:515-520
3. Szallasi A, Blumberg PM (1990) Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor. Life Sci 47:1399-1408
4. Avelino A, Cruz F (2006) TRPV1 (vanilloid receptor) in the urinary tract: Expression, function and clinical applications. Naunyn Schmiedeberg's Arch Pharmacol 373:287-299
5. Silva C, Rio ME, Cruz F (2000) Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: Long-term results for the treatment of detrusor hyperreflexia. Eur Urol 38:444-452
6. Silva C, Ribeiro MJ, Cruz F (2002) The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol 168:575-579
7. Kissin EY, Freitas CF, Kissin I (2005) The effects of intraarticular resiniferatoxin in experimental knee-joint arthritis. Anesth Analg 101:1433-1439
8. Brown DC, Iadarola MJ, Perkowski SZ, Erin H, Shofer F, Laszlo KJ, Olah Z, Mannes AJ (2005) Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model. Anesthesiology 103:1052-1059
9. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 187:116-126
10. Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pfluger H (2005) Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis. Eur Urol 47:393-397
11. Rosenberg MT, Hazzard M (2005) Prevalence of interstitial cystitis symptoms in women: A population based study in the primary care office. J Urol 174:2231-2234
12. Kallestrup EB, Jorgensen SS, Nordling J, Hald T (2005) Treatment of interstitial cystitis with Cystistat: A hyaluronic acid product. Scand J Urol Nephrol 39:143-147
13. Jones CA, Nyberg L (1997) Epidemiology of interstitial cystitis. Urology 49(5A Suppl):2-9
14. Gupta SK, Pidcock L, Parr NJ (2005) The potassium sensitivity test: A predictor of treatment response in interstitial cystitis. BJU Int 96:1063-1066
15. Parsons CL, Stein PC, Bidair M, Lebow D (1994) Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 13:515-520
16. Moldwin RM, Sant GR (2002) Interstitial cystitis: A pathophysiology and treatment update. Clin Obstet Gynecol 45:259-272
17. Morales A, Emerson L, Nickel JC (1996) Treatment of refractory interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 7:215-220
18. Ruggieri MR, Chelsky MJ, Rosen SI, Shickley TJ, Hanno PM (1994) Current findings and future research avenues in the study of interstitial cystitis. Urol Clin North Am 21:163-176
19. Nordling J, Jorgensen S, Kallestrup E (2001) Cystistat for the treatment of interstitial cystitis: A 3-year follow-up study. Urology 57(6 Suppl 1):123
20. Parsons CL (2004) Current strategies for managing interstitial cystitis. Expert Opin Pharmacother 5:287-293
21. Parsons CL, Housley T, Schmidt JD, Lebow D (1994) Treatment of interstitial cystitis with intravesical heparin. Br J Urol 73:504-507
22. Parsons CL (1982) Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysulfate. J Urol 127:167-169
23. Iavazzo C, Athanasiou S, Pitsouni E, Falagas ME (2007) Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis. Eur Urol 51:1534-1541
24. Peng CH, Kuo HC (2007) Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis. Urol Int 78:78-81
25. Apostolidis A, Gonzales GE, Fowler CJ (2006) Effect of intravesical resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation. Eur Urol 50:1299-1305
26. Payne CK, Mosbaugh PG, Forrest JB, Evans RJ, Whitmore KE, Antoci JP, Perez-Marrero R, Jacoby K, Diokno AC, O'Reilly KJ, Griebling TL, Vasavada SP, Yu AS, Frumkin LR, ICOS RTX Study Group (Resiniferatoxin Treatment for Interstitial Cystitis) (2005) Intravesical resiniferatoxin for the treatment of interstitial cystitis: A randomized, double-blind, placebo controlled trial. J Urol 173:1590-1594
27. Chen TY, Corcos J, Camel M, Ponsot Y, Tu le M (2005) Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC). Int Urogynecol J Pelvic Floor Dysfunct 16:293-297
28. Lazzeri M, Spinelli M, Beneforti P, Malaguti S, Giardiello G, Turini D (2004) Intravesical infusion of resiniferatoxin by a temporary in situ drug delivery system to treat interstitial cystitis: A pilot study. Eur Urol 45:98-102
29. Lazzeri M, Beneforti P, Spinelli M, Zanollo A, Barbagli G, Turini D (2000) Intravesical resiniferatoxin for the treatment of hypersensitive disorder: A randomized placebo controlled study. J Urol 164:676-679
30. Giannantoni A, Porena M, Costantini E, Zucchi A, Mearini L, Mearini E (2008) Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year follow-up. J Urol 179:1031-1034